Abbott Laboratories (ABT) Change in Cash (2009 - 2026)

Abbott Laboratories has disclosed Change in Cash across 18 years of filings, most recently posting -$1.7 billion for Q2 2026.

• In Q2 2026, Change in Cash fell 505.49% year-over-year to -$1.7 billion; the TTM figure through Jun 2026 stood at -$1.8 billion (down 5030.56% YoY), while the FY2025 annual figure was $906.0 million, up 25.83% from the prior year.
• Change in Cash came in at -$1.7 billion for Q2 2026 at Abbott Laboratories, up from -$1.7 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.3 billion in Q2 2022 to a low of -$2.1 billion in Q1 2022.
• Average Change in Cash over 5 years is -$260.8 million, with a median of $122.5 million recorded in 2023.
• Year-over-year, Change in Cash jumped 1643.1% in 2025 and tumbled 505.49% in 2026.
• Over 5 years, Change in Cash stood at $288.0 million in 2022, then tumbled by 35.07% to $187.0 million in 2023, then sank by 68.98% to $58.0 million in 2024, then jumped by 1643.1% to $1.0 billion in 2025, then tumbled by 268.05% to -$1.7 billion in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$1.7 billion in Q2 2026, -$1.7 billion in Q1 2026, and $1.0 billion in Q4 2025.